Hi,
moomoo ID:NaN
Log Out
English
Back
Download
Log in to access Online Inquiry
Quotes
Detailed Quotes
Company Overview
Company ProfileCompany Executives
Financial Analysis
Main CompositionKey IndicatorsFinancial Statement
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > APRE Aprea Therapeutics > Detailed Quotes

APRE Aprea Therapeutics

Watchlist
0.474
-0.003-0.63%
Close  01/27 16:00 ET
0.498
+0.024+4.98%
Post Mkt Price 01/27 19:54 ET
High
0.490
Open
0.490
Turnover
29.84K
Low
0.469
Pre Close
0.477
Volume
62.46K
Market Cap
25.12M
P/E(TTM)
Loss
52wk High
2.210
Shares
53.00M
P/E(Static)
Loss
52wk Low
0.304
Float Cap
19.09M
Bid/Ask %
-75.00%
Historical High
53.110
Shs Float
40.28M
Volume Ratio
0.53
Historical Low
0.304
Dividend TTM
--
Div Yield TTM
--
P/B
0.94
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.16%
Amplitude
4.40%
Avg Price
0.477
Lot Size
1
Float Cap
19.09M
Bid/Ask %
-75.00%
Historical High
53.110
Shs Float
40.28M
Volume Ratio
0.53
Historical Low
0.304
Dividend TTM
--
P/B
0.94
Dividend LFY
--
Turnover Ratio
0.16%
Amplitude
4.40%
Avg Price
0.477
Lot Size
1
Post-Market
5D
1D
1W
1M
1Q
1Y
Price Forecast

News

Comment

News

Announcement

All

Earnings Report

Related Transactions

Changes In Ownership

Major Events

Other

No More
Company Overview More
Aprea Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the provision of cancer therapeutics. It is involved in the development and commercialization of novel cancer therapeutics that reactivate mutant p53 tumor suppressor protein. The company was founded by Vladimir Bykov, Klas Gota Wiman, Staffan Stromblad, Natalia Issaeva, Galina Selivanova, and Wen Jie Bao in 2002 and is headquartered in Boston, MA.
CEO： Dr. Oren Gilad, PhD
Market： NASDAQ
Listing Date： 10/03/2019
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Get Started
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist